User profiles for Julian Buchrieser
 | Julian BuchrieserResearcher, Institut Pasteur Verified email at pasteur.fr Cited by 4492 |
[HTML][HTML] Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
…, F Guivel-Benhassine, C Planchais, J Buchrieser… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …
[HTML][HTML] Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies
…, I Staropoli, F Porrot, C Planchais, J Buchrieser… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …
were first identified in the United Kingdom and South Africa, respectively, and have since …
Syncytia formation by SARS‐CoV‐2‐infected cells
J Buchrieser, J Dufloo, M Hubert, B Monel… - The EMBO …, 2020 - embopress.org
Severe cases of COVID‐19 are associated with extensive lung damage and the presence of
infected multinucleated syncytial pneumocytes. The viral and cellular mechanisms …
infected multinucleated syncytial pneumocytes. The viral and cellular mechanisms …
[PDF][PDF] A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response
Microglia are increasingly implicated in brain pathology, particularly neurodegenerative
disease, with many genes implicated in Alzheimer's, Parkinson's, and motor neuron disease …
disease, with many genes implicated in Alzheimer's, Parkinson's, and motor neuron disease …
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
…, H Mouquet, LA Chakrabarti, J Buchrieser… - The EMBO …, 2021 - embopress.org
Severe COVID‐19 is characterized by lung abnormalities, including the presence of syncytial
pneumocytes. Syncytia form when SARS‐CoV‐2 spike protein expressed on the surface of …
pneumocytes. Syncytia form when SARS‐CoV‐2 spike protein expressed on the surface of …
[HTML][HTML] Distinct evolution of SARS-CoV-2 Omicron XBB and BA. 2.86/JN. 1 lineages combining increased fitness and antibody evasion
…, L Avon, WH Bolland, M Hubert, J Buchrieser… - Nature …, 2024 - nature.com
The unceasing circulation of SARS-CoV-2 leads to the continuous emergence of novel viral
sublineages. Here, we isolate and characterize XBB.1, XBB.1.5, XBB.1.9.1, XBB.1.16.1, EG.…
sublineages. Here, we isolate and characterize XBB.1, XBB.1.5, XBB.1.9.1, XBB.1.16.1, EG.…
[HTML][HTML] Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells
E Bonsergent, E Grisard, J Buchrieser… - Nature …, 2021 - nature.com
Extracellular vesicles (EVs), including exosomes, are thought to mediate intercellular
communication through the transfer of cargoes from donor to acceptor cells. Occurrence of EV-…
communication through the transfer of cargoes from donor to acceptor cells. Occurrence of EV-…
The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation
MM Rajah, A Bernier, J Buchrieser… - Journal of Molecular …, 2022 - Elsevier
Syncytia are formed when individual cells fuse. SARS-CoV-2 induces syncytia when the viral
spike (S) protein on the surface of an infected cell interacts with receptors on neighboring …
spike (S) protein on the surface of an infected cell interacts with receptors on neighboring …
Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
…, F Guivel-Benhassine, C Planchais, J Buchrieser… - BioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 . It has in the meantime spread to many countries and is expected to rapidly …
South Africa 1 , 2 . It has in the meantime spread to many countries and is expected to rapidly …